BHC

Bausch Health Cos INC

-$385.7M

Net Activity

Institutions Holding

235

Popularity Rank

#2523

Avg Weight

0.13%

Total Value

$1.3B

Ownership Trend

235 institutions currently hold BHC, with 111 net buyers and 96 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

96

Net Buying Institutions

111

Key Holders

Key Holders

Top 5 by Value

P&
Paulson & Co. INC.
$395.6M
GA
Goldentree Asset Management LP
$187.0M
RB
Royal Bank Of Canada
$61.4M
NH
Nomura Holdings INC
$48.5M
HO
Healthcare Of Ontario Pension Plan Trust Fund
$43.2M

Top 5 by Conviction

P&
Paulson & Co. INC.
12.71%
GA
Goldentree Asset Management LP
11.09%
FC
Fore Capital, LLC
1.57%
MP
MFN Partners Management, LP
0.68%
KK
Kohlberg Kravis Roberts & Co. L.P.
0.53%
View all 235 holding institutions

Quarterly Activity

Recent Activity

+$408.2M

Total Buy Value

$343.5M

Total Sell Value

New buy24
Trim63
Add87
Sold out33

111

Net Buyers

96

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-01
2026-07-01

Michael Goettler resigned from Bausch Health's board, effective June 30, 2026, because he's becoming President and CEO of Knoa Pharma LLC. The company confirmed his resignation was not due to any disagreement with Bausch Health's operations, policies, or practices.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding BAUSCH HEALTH COS INC (BHC)?
Major stakeholders currently include Paulson & Co. INC. ($395.6M), Goldentree Asset Management LP ($187.0M), Royal Bank Of Canada ($61.4M). Based on the latest 13F filings, there are a total of 235 tracked investment funds and institutions maintaining positions in BHC.
What is the overall institutional sentiment toward BHC recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $385.7M, driven by 111 managers accumulating shares while 96 reduced their exposure.
Which institutions have been selling or reducing their BHC positions?
In the latest period, 63 funds trimmed their holdings, and 33 managers completely exited their positions. The aggregate reported sell value was $343.5M.
Are there any notable investors adding BHC to their portfolios?
Yes, buying activity remains notable. 24 institutions opened new positions in {ticker}, and 87 existing holders added to their shares. The total reported buy value for the quarter amounted to $408.2M.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

199 institutions currently hold both BHC and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

197 institutions currently hold both BHC and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

199 institutions currently hold both BHC and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail